Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

200678 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Clinical Immunology

Volume 26, Issue 4, pp. 388-395

Field-Weighted Citation Impact: 1.73